• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down3.39% Nasdaq Down4.12%

    Alnylam Pharmaceuticals, Inc. (ALNY)

    -NasdaqGS
    54.31 Down 2.64(4.64%) Jun 24, 4:00PM EDT
    |After Hours : 54.31 0.00 (0.00%) Jun 24, 5:23PM EDT
    Company EventsGet Company Events for:
    Upcoming Events 
    DateEvent
    Aug 4 - Aug 8, 2016 (Est.)Earnings announcement
    Recent Events 
    DateEvent
    15-Jun-16ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
    11-Jun-16Alnylam Pharmaceuticals Inc Conference Call to Discuss Phase 1/2 Clinical Results with ALN-CC5 scheduled for 8:30 am ET today
    6-May-16ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
    4-May-16ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
    2-May-16Alnylam Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
    2-May-16ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations a
    8-Apr-16ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events
    5-Apr-16Coverage initiated on Alnylam Pharma by Chardan Capital Markets
    12-Feb-16ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report
    11-Feb-16ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    11-Jan-16ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    22-Dec-15ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi
    18-Dec-15ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
    9-Nov-15ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    2-Oct-15ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Financial Statements and Exhibits
    7-Aug-15ALNYLAM PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report
    6-Aug-15ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
    14-Jul-15ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Fi
    10-Jul-15ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
    10-Jun-15ALNYLAM PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure